L3 Structural and functional proton MRI assessment of cystic fibrosis lung disease in people with F508-del mutation von Brooke, J, Safavi, S, Prayle, AP, Ng, C, Alappadan, J, Bradley, C, Cooper, A, Munidasa, S, Zanette, B, Santyr, GE, Barr, H, Major, G, Smyth, A, Gowland, P, Francis, S, Hall, IP

Volltext

P82 Comparison of rsv hospitalisation in preterm infants with chronic lung disease who do not qualify for palivizumab prophylaxis with those who qualify in nottingham, uk von Tsilika, L, Batra, D, Prayle, AP, Hurley, M, Bhatt, JM

Volltext

P81 What is the ideal target preterm population that might benefit from the expensive palivizumab prophylaxis? von Tsilika, L, Batra, D, Prayle, AP, Hurley, M, Bhatt, JM

Volltext

Growth and nutrition in children with ataxia telangiectasia von Stewart, E, Prayle, AP, Tooke, A, Pasalodos, S, Suri, M, Bush, A, Bhatt, JM

Volltext

Is cystic fibrosis survival improving in excess to that of the general population for England and Wales and the USA? von Hurley, MN, McKeever, T, Prayle, AP, Fogarty, A, Smyth, AR

Volltext

P09 The Use of Cochrane Reviews in Clinical Guidelines For Respiratory Disease in Children in the United Kingdom – a Systematic Review von Cox, THN, Smyth, AR, Prayle, AP, Hughes, DA, Rycroft-Malone, J, Thomas, K

Volltext